BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30173326)

  • 1. Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature.
    Theodorou-Kanakari A; Karampitianis S; Karageorgou V; Kampourelli E; Kapasakis E; Theodossiadis P; Chatziralli I
    Adv Ther; 2018 Oct; 35(10):1510-1518. PubMed ID: 30173326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
    Pemp B; Kircher K; Reitner A
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idebenone for Leber's hereditary optic neuropathy.
    Gueven N
    Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologically Responsive Mitochondrial Gene Therapy in an Allotopic Expression-Independent Manner Cures Leber's Hereditary Optic Neuropathy.
    Wang Y; Hu LF; Cui PF; Qi LY; Xing L; Jiang HL
    Adv Mater; 2021 Oct; 33(41):e2103307. PubMed ID: 34431574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leber's Hereditary Optic Neuropathy as a Promising Disease for Gene Therapy Development.
    Karaarslan C
    Adv Ther; 2019 Dec; 36(12):3299-3307. PubMed ID: 31605306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy.
    Wong RCB; Lim SY; Hung SSC; Jackson S; Khan S; Van Bergen NJ; De Smit E; Liang HH; Kearns LS; Clarke L; Mackey DA; Hewitt AW; Trounce IA; Pébay A
    Aging (Albany NY); 2017 Apr; 9(4):1341-1350. PubMed ID: 28455970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy.
    Zhang Y; Tian Z; Yuan J; Liu C; Liu HL; Ma SQ; Li B
    Curr Gene Ther; 2017; 17(4):320-326. PubMed ID: 29189152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
    Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
    Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
    Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
    PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy].
    Barnils N; Mesa E; Muñoz S; Ferrer-Artola A; Arruga J
    Arch Soc Esp Oftalmol; 2007 Jun; 82(6):377-80. PubMed ID: 17573650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
    Lyseng-Williamson KA
    Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
    Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
    Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel use of idebenone in Leber's hereditary optic neuropathy in Hong Kong.
    Cheng SW; Ko CH; Yau SK; Mak C; Yuen YF; Lee CY
    Hong Kong Med J; 2014 Oct; 20(5):451-4. PubMed ID: 25307075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Leber's hereditary optic neuropathy: An overview of recent developments.
    Zuccarelli M; Vella-Szijj J; Serracino-Inglott A; Borg JJ
    Eur J Ophthalmol; 2020 Nov; 30(6):1220-1227. PubMed ID: 32552047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON).
    Chan JW; Sultan W; Karanjia R; Sadun AA
    Mitochondrion; 2022 Jan; 62():181-186. PubMed ID: 34915201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Leber's Hereditary Optic Neuropathy.
    Karanjia R; Chahal J; Ammar M; Sadun AA
    Curr Pharm Des; 2017; 23(4):624-628. PubMed ID: 28128056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solutions to a Radical Problem: Overview of Current and Future Treatment Strategies in Leber's Hereditary Opic Neuropathy.
    Spiegel SJ; Sadun AA
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Treatments for Leber's Hereditary Optic Neuropathy and Other Genetic Causes of Visual Loss.
    Bakaeva T; Mallery R; Prasad S
    Semin Neurol; 2019 Dec; 39(6):732-738. PubMed ID: 31847044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leber's hereditary optic neuropathy - Case report.
    Iorga RE; Mihailovici R; Ozturk MR; Costin D
    Rom J Ophthalmol; 2018; 62(1):64-71. PubMed ID: 29796436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy.
    Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B
    EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.